Ryman Healthcare

Aging Demographics And Urban Demand Will Transform Retirement Villages

AnalystHighTarget

Not Invested

Consensus Narrative from 4 Analysts

Published

20 Aug 25

Updated

20 Aug 25

AnalystHighTarget's Fair Value

NZ$3.50

30.9% undervalued

20 Aug

NZ$2.42

-51.6%

3.4%

Author's Valuation

NZ$3.5

30.9% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

NZ$3.5

30.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

7.10%

Healthcare Services revenue growth rate

0.26%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.94%

Calculation

NZ$486.14m

Earnings '28

10.94x

PE Ratio '28

NZ$5.32b

Market Cap '28

NZ$5.32b

Market Cap '28

1.24b

No. shares '28

NZ$4.28

Share Price '28

NZ$4.28 Share Price '28

Discounted to 2025 @ 6.94% p.a.

NZ$3.50

Fair Value '25